Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Aug 2026 → Aug 2028
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 2026 to Aug 2028
    • Start date: Jul 10, 2022 to Jul 1, 2026
    • Eligibility criteria expanded, about 9 words
  2. Primary and study completion dates: Aug 2025 to Aug 2026v5
  3. Primary and study completion dates: Aug 2024 to Aug 2025
    • Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Aug 10, 2024 to Aug 2024
    • Study completion date: Aug 10, 2025 to Aug 2024
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Mayo Clinic
1,027 trials monitored
See 130 trials at risk
Obesity
3,909 trials monitored
See 165 trials at risk
This study is trying to determine whether the success of bariatric surgery can be predicted by evaluating the dietary sugar absorptive characteristics in the small intestine and if there is any gene expression change on the dietary sugar absorptive characteristics.
Trial Details
NCT Number NCT05408728
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Obese, Healthy, Bariatric Surgery Candidate
Related terms Obesity
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov